Divergent brain changes in two audiogenic rat strains: a voxel-based morphometry and diffusion tensor imaging comparison of the Genetically Epilepsy Prone Rat (GEPR-3) and the Wistar Audiogenic Rat (WAR). Lee YC, Rodriguez O, Albanese C, Santos VR, Cortes de Oliveira JA, Ferreira Donatti AL, Fernandes A; Garcia-Cairasco N, N’Gouemo P, Forcelli PA. Neurobiol Dis. 2017 Dec 21:111;80-90. PMID: 29274430.
Cholecystokinin receptor antagonist alters pancreatic cancer. Smith JP, Wang S, Nadella S, Jablonski SA, Weiner LM. Cancer Immunol Immunother. 2017 Oct 17. doi: 10.1007/s00262-017-2077-9.
Addition of forelimb training reduces gains from robotic gait training in a rat model of spinal cord injury. Neckel ND, Dai H, Rodriguez OC. IEEE Int Conf Rehabil Robot. 2017 Jul;2017:346-351. doi: 10.1109/ICORR.2017.8009271. PMID: 2881384
2016
In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis. Hong SH, Tilan JU, Galli S, Acree R, Connors K, Mahajan A, Wietlisbach L, Polk T, Izycka-Swieszewska E, Lee YC, Cavalli LR, Rodriguez OC, Albanese C, Kitlinska JB. J Vis Exp. 2016 Dec 9;(118). doi: 10.3791/54532. PMID: 28060251
Neuropeptide Y as a Biomarker and Therapeutic Target for Neuroblastoma. Galli S, Naranjo A, Van Ryn C, Tilan JU, Trinh E, Yang C, Tsuei J, Hong SH, Wang H, Izycka-Swieszewska E, Lee YC, Rodriguez OC, Albanese C, Kitlinska J. Am J Pathol. 2016 Nov;186(11):3040-3053. doi: 10.1016/j.ajpath.2016.07.019. PMID: 27743558
Protease induced plasticity: matrix metalloproteinase-1 promotes neurostructural changes though activation of protease activated receptor 1. Allen M, Ghosh S, Ahern GP, Villapol S, Maguire-Zeiss KA, Conant K. Sci Rep. 2016 Oct 20; (6): 35497. doi: 10.1038/srep35497. PMID: 27762280
Ezrin Inhibition Up-regulates Stress Response Gene Expression. Çelik H, Bulut G, Han J, Graham GT, Minas TZ, Conn EJ, Hong SH, Pauly GT, Hayran M, Li X, Özdemirli M, Ayhan A, Rudek MA, Toretsky JA, Üren A . J Biol Chem. 2016 Jun 17; 291(25): 13257–70. doi: 10.1074/jbc.M116.718189. PMID: 27137931
Manganese-Enhanced Magnetic Resonance Imaging as a Diagnostic and Dispositional Tool after Mild-Moderate Blast Traumatic Brain Injury. Rodriguez O, Schaefer ML, Wester B, Lee YC, Boggs N, Conner HA, Merkle AC, Fricke ST, Albanese C, Koliatsos VE. J Neurotrauma. 2016 Apr 1;33(7):662-71. doi: 10.1089/neu.2015.4002. PMID: 26414591
2015
Encapsulation of temozolomide in a tumor-targeting nanocomplex enhances anti-cancer efficacy and reduces toxicity in a mouse model of glioblastoma. Kim SS, Rait A, Kim E, DeMarco J, Pirollo KF, Chang EH. Cancer Lett. 2015 Dec 1;369(1):250-8. doi: 10.1016/j.canlet.2015.08.022. Epub 2015 Sep 2. PMID: 26325605
Kim SS, Rait A, Kim E, DeMarco J, Pirollo KF, Chang EH. Encapsulation of temozolomide in a tumor-targeting nanocomplex enhances anti-cancer efficacy and reduces toxicity in a mouse model of glioblastoma. Cancer Lett. 2015 Dec 1;369(1):250-8. doi: 10.1016/j.canlet.2015.08.022. PMID: 26325605. PMCID: PMC4600672
The p53 tumor suppressor protein protects against chemotherapeutic stress and apoptosis in human medulloblastoma cells. Waye S, Naeem A, Choudhry MU, Parasido E, Tricoli L, Sivakumar A, Mikhaiel JP, Yenugonda V, Rodriguez OC, Karam SD, Rood BR, Avantaggiati ML, Albanese C. Aging (Albany NY). 2015 Oct;7(10):854-68. PMID: 26540407
Effects of altered ephrin-A5 and EphA4/EphA7 expression on tumor growth in a medulloblastoma mouse model. Bhatia S, Hirsch K, Baig NA, Rodriguez O, Timofeeva O, Kavanagh K, Lee YC, Wang XJ, Albanese C, Karam SD. J Hematol Oncol. 2015 Sep 7;8:105. doi: 10.1186/s13045-015-0202-9. PMID: 26345456
GSK-3β dysregulation contributes to parkinson’s-like pathophysiology with associated region-specific phosphorylation and accumulation of tau and α-synuclein. Credle JJ, George JL, Wills J, Duka V, Shah K, Lee YC, Rodriguez O, Simkins T, Winter M, Moechars D, Steckler T, Goudreau J, Finkelstein DI, Sidhu A. Cell Death Differ. 2015 May;22(5):838-51. doi: 10.1038/cdd.2014.179. PMID: 25394490
Metabotropic glutamate receptor 1 acts as a dependence receptor creating a requirement for glutamate to sustain the viability and growth of human melanomas. Gelb T, Pshenichkin S, Rodriguez OC, Hathaway HA, Grajkowska E, DiRaddo JO, Wroblewska B, Yasuda RP, Albanese C, Wolfe BB, Wroblewski JT. Oncogene. 2015 May 21;34(21):2711-20. doi: 10.1038/onc.2014.231. PMID: 25065592
Knockdown of EphB1 receptor decreases medulloblastoma cell growth and migration and increases cellular radiosensitization. Bhatia S, Baig NA, Timofeeva O, Pasquale EB, Hirsch K, MacDonald TJ, Dritschilo A, Lee YC, Henkemeyer M, Rood B, Jung M, Wang XJ, Kool M, Rodriguez O, Albanese C, Karam SD. Oncotarget. 2015 Apr 20;6(11):8929-46. PMID: 25879388
High neuropeptide Y release associates with Ewing sarcoma bone dissemination – in vivo model of site-specific metastases. Hong SH, Tilan JU, Galli S, Izycka-Swieszewska E, Polk T, Horton M, Mahajan A, Christian D, Jenkins S, Acree R, Connors K, Ledo P, Lu C, Lee YC, Rodriguez O, Toretsky JA, Albanese C, Kitlinska J. Oncotarget. 2015 Mar 30;6(9):7151-65. PMID: 25714031
A tumor-targeting p53 nanodelivery system limits chemoresistance to temozolomide prolonging survival in a mouse model of glioblastoma multiforme. Kim SS, Rait A, Kim E, Pirollo KF, Chang EH. Nanomedicine. 2015 Feb;11(2):301-11. doi: 10.1016/j.nano.2014.09.005. PMID: 25240597
Kim SS, Rait A, Kim E, Pirollo KF, Chang EH. A tumor-targeting p53 nanodelivery system limits chemoresistance to temozolomide prolonging survival in a mouse model of glioblastoma multiforme. Nanomedicine. 2015 Feb;11(2):301-11. doi: 10.1016/j.nano.2014.09.005. PMID: 25240597. PMCID: PMC4330129
2014
Integration of Network Biology and Imaging to Study Cancer Phenotypes and Responses.Tian Y, Wang SS, Zhang Z, Rodriguez OC, Petricoin E 3rd, Shih IeM, Chan D, Avantaggiati M, Yu G, Ye S, Clarke R, Wang C, Zhang B, Wang Y, Albanese C IEEE/ACM Trans Comput Biol Bioinform. 2014 Nov-Dec;11(6):1009-19. doi: 10.1109/TCBB.2014.2338304. PMID: 25750594. PMCID: PMC4348060
The effects of particle shape and size on T2 relaxation in magnetic resonance imaging. York JN, Albanese C, Rodriguez O, Le YC, Ackun-Farmmer M, Van Keuren E. The effects of particle shape and size on T2 relaxation in magnetic resonance imaging. J Biomed Nanotechnol. 2014 Nov;10(11):3392-6. PMID: 26000397
2013
Magnetic nanobeads as potential contrast agents for magnetic resonance imaging.Pablico-Lansigan MH, Hickling WJ, Japp EA, Rodriguez OC, Ghosh A, Albanese C, Nishida M, Van Keuren E, Fricke S, Dollahon N, Stoll SL ACS Nano. 2013 Oct 22;7(10):9040-8. doi: 10.1021/nn403647t. PMID: 24047405
VBP15, a novel anti-inflammatory and membrane-stabilizer, improves muscular dystrophy without side effects. Heier CR, Damsker JM, Yu Q, Dillingham BC, Huynh T, Van der Meulen JH, Sali A, Miller BK, Phadke A, Scheffer L, Quinn J, Tatem K, Jordan S, Dadgar S, Rodriguez OC, Albanese C, Calhoun M, Gordish-Dressman H, Jaiswal JK, Connor EM, McCall JM, Hoffman EP, Reeves EK, Nagaraju K. EMBO Mol Med. 2013 Oct;5(10):1569-85. doi: 10.1002/emmm.201302621. PMID: 24014378. PMCID: PMC3799580
Therapeutic and space radiation exposure of mouse brain causes impaired DNA repair response and premature senescence by chronic oxidant production. Suman S, Rodriguez OC, Winters TA, Fornace AJ Jr, Albanese C, Datta K. Aging (Albany NY). 2013 Aug;5(8):607-22. doi: 10.18632/aging.100587. PMID: 23928451. PMCID: PMC3796214
Preclinical magnetic resonance imaging and systems biology in cancer research: current applications and challenges.Albanese C, Rodriguez OC, VanMeter J, Fricke ST, Rood BR, Lee Y, Wang SS, Madhavan S, Gusev Y, Petricoin EF 3rd, Wang Y Am J Pathol. 2013 Feb;182(2):312-8. doi: 10.1016/j.ajpath.2012.09.024. PMID: 23219428. PMCID: PMC3969503
2012
Quantifying the CDK inhibitor VMY-1-103’s activity and tissue levels in an in vivo tumor model by LC-MS/MS and by MRI. Sirajuddin P, Das S, Ringer L, Rodriguez OC, Sivakumar A, Lee YC, Üren A, Fricke ST, Rood B, Ozcan A, Wang SS, Karam S, Yenugonda V, Salinas P, Petricoin E 3rd, Pishvaian M, Lisanti MP, Wang Y, Schlegel R, Moasser B, Albanese C Cell Cycle. 2012 Oct 15;11(20):3801-9. doi: 10.4161/cc.21988. PMID: 22983062. PMCID: PMC3495823
Combined inhibition of cell death induced by apoptosis inducing factor and caspases provides additive neuroprotection in experimental traumatic brain injury. Piao CS, Loane DJ, Stoica bA, Li S, Hanscom M, Cabatbat R, Blomgren K, Faden AI. Neurobiol Dis 2012 Jun;46(3):745-58. doi: 10.1016/j.nbd.2012.03.018. PMID: 22426396. PMCID: PMC3352990
2011
Delayed Inflammatory mRNA and protein expression after spinal chord injury. Byrnes KR, Washington PM, Knoblach SM, Hoffman E, Faden AI. J Neuroinflammation 2011 Oct; 8:130. doi: 10.1186/1742-2094-8-130.. PMID: 21975064. PMCID: PMC3198932
Hyperphosphorylated Tau in an α-synuclein-overexpressing transgenic model of Parkinson’s disease. Haggerty T, Credle J, Rodriguez O, Wills J, Oaks AW, Masliah E, Sidhu A. Eur J Neurosci. 2011 May;33(9):1598-610. doi: 10.1111/j.1460-9568.2011.07660.x. PMID: 21453448. PMCID: PMC3086951
Arsenic trioxide inhibits human cancer cell growth and tumor development in mice by blocking Hedgehog/GLI pathway. Beauchamp EM, Ringer L, Bulut G, Sajwan KP, Hall MD, Lee YC, Peaceman D, Ozdemirli M, Rodriguez O, Macdonald TJ, Albanese C, Toretsky JA, Uren A. J Clin Invest. 2011 Jan;121(1):148-60. doi: 10.1172/JCI42874. PMID: 21183792. PMCID: PMC3007144
Induction of metastatic gastric cancer by peroxisome proliferator-activated receptorδ activation. Pollock CB, Rodriguez O, Martin PL, Albanese C, Li X, Kopelovich L, Glazer RI. PPAR Res. 2010; 2010:571783. doi: 10.1155/2010/571783. PMID: 21318167. PMCID: PMC3026990
Pathophysiological response to experimental diffuse brain trauma differs as a function of developmental age. Cernak I, Chang T, Ahmed FA, Cruz MI, Vink R, Stoica B, Faden AI. Dev Neuroscience 2010;32:442-453. doi: 10.1159/000320085. PMID: 20948187
In vivo magnetic resonance volumetric and spectroscopic analysis of mouse prostate cancer models. Fricke ST, Rodriguez O, Vanmeter J, Dettin LE, Casimiro M, Chien CD, Newell T, Johnson K, Ileva L, Ojeifo J, Johnson MD, Albanese C. Prostate. 2006 May 15;66(7):708-17. doi: 10.1002/pros.20392. PMID: 16425198
Modulation of ABCA1 by an LXR agonist reduces beta-amyloid levels and improves outcome after traumatic brain injury. Loane DJ, Washington PM, Vardanian L, Pocivavsek A, Hoe HS, Duff KE, Cernak I, Rebeck GW, Faden AI, Burns MP. J Neurotauma 2011 Feb;28(2):225-36. doi: 10.1089/neu.2010.1595. PMID: 21175399. PMCID: PMC3037807
Activation of metabotropic glutamate receptor 5 improves recovery after spinal cord injury in rodents. Byrnes KR, Stoica B, Riccio A, Pajoohesh-Ganji A, Loane DJ, Faden AI. Ann Neurol 2009 Jul;66(1):63-74. doi: 10.1002/ana.21673. PMID: 19670441. PMCID: PMC3755738
Nanodelivery of MRI contrast agent enhances sensitivity of detection of lung cancer metastases. Freedman M, Chang EH, Zhou Q, Pirollo KF. Acad Radiol. 2009 May;16(5):627-37. doi: 10.1016/j.acra.2008.12.002. PMID: 19345904. PMCID: PMC2689945
Amyloid precursor protein secretases as therapeutic targets for traumatic brain injury. Loane DJ, Pocivavsek A, Moussa CE, Thompson R, Matsouka Y, Faden AI, Rebeck GW,, Burns MP. Nat Med 2009 Apr;15(4):377-9. doi: 10.1038/nm.1940. PMID: 19287391. PMCID: PMC2844765
The role of the neuropeptide Y2 receptor in liporemodeling: neuropeptide Y-mediated adipogenesis and adipose graft maintenance. Baker SB, Cohen M, Kuo L, Johnson M, Al-Attar A, Zukowska Z. Plast Reconstr Surg. 2009 Feb;123(2):486-92. doi: 10.1097/PRS.0b013e3181954c80. PMID: 19182605. PMCID: PMC2659679
Metabotropic glutamate receptors as targets for multipotential treatment of neurological disorders. Byrnes KR, Loane DJ, Faden AI. Neurotherapeutics 2009 Jan;6(1):94-107. doi: 10.1016/j.nurt.2008.10.038. PMID: 19110202. PMCID: PMC2634659
Contrast-enhanced in vivo imaging of breast and prostate cancer cells by MRI. Rodriguez O, Fricke S, Chien C, Dettin L, VanMeter J, Shapiro E, Dai HN, Casimiro M, Ileva L, Dagata J, Johnson MD, Lisanti MP, Koretsky A, Albanese C Cell Cycle. 2006 Jan;5(1):113-9. doi: 10.4161/cc.5.1.2295. PMID: 16340310
